Published in early 2020, this consensus guideline has been developed in order to reexamine the role of cryopreserved amniotic membrane (CAM) in the management of cornea-involved ocular surface disease and the preparation of the ocular surface for refractive cataract surgery, all of which present continued unmet needs.
Developed from a roundtable discussion with:
Marguerite McDonald, MD, Neel Desai, MD, Clifford Salinger, MD, Mark Milner, MD and John Sheppard, MD
Five renowned experts in anterior segment eye disease and surgery highlighted their recommendations for the use of CAM in the following indications:
Marguerite McDonald, MD
Neel Desai, MD
Clifford Salinger, MD
Mark Milner, MD
John Sheppard, MD
5 renowned optometry experts in ocular surface disease management will highlight the existing consensus guideline and how it can be applied effectively by the Doctor of Optometry and/or through co-management with corneal specialists in their practice or community.
This consensus guideline has been developed in order to reexamine the role of CAM in the management of cornea-involved ocular surface diseases, all of which present continued
The group will re-examine the role of CAM in the management of persistent epithelial defect (PED), corneal ulcer/infectious keratitis, recurrent corneal erosion (RCE), severe dry eye disease (DED), epithelial basement membrane dystrophy (EBMD), neurotrophic keratitis (NK), and the role of optimizing the ocular surface prior to refractive cataract surgery.